Hepatic fibrosis with hepatic sclerosis
ICD-10 K74.2 is a billable code used to indicate a diagnosis of hepatic fibrosis with hepatic sclerosis.
Hepatic fibrosis with hepatic sclerosis is characterized by the excessive accumulation of extracellular matrix proteins, leading to scarring of the liver tissue. This condition often arises as a consequence of chronic liver diseases such as hepatitis, alcohol abuse, or non-alcoholic fatty liver disease. Clinically, patients may present with symptoms such as fatigue, jaundice, ascites, and abdominal discomfort, although many may remain asymptomatic in the early stages. The liver anatomy involved includes hepatocytes, portal tracts, and the hepatic vasculature, which become progressively altered as fibrosis advances. Disease progression can lead to cirrhosis, portal hypertension, and ultimately liver failure if not managed appropriately. Diagnostic considerations include liver function tests, imaging studies like ultrasound or MRI, and liver biopsy, which can confirm the degree of fibrosis and rule out other conditions. Regular monitoring and early intervention are crucial to prevent complications associated with advanced liver disease.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K74.2 specifically covers hepatic fibrosis accompanied by hepatic sclerosis, often resulting from chronic liver diseases such as viral hepatitis, alcoholic liver disease, or autoimmune hepatitis. It is essential to differentiate this from other forms of liver fibrosis that do not involve sclerosis.
K74.2 should be used when there is clear evidence of hepatic fibrosis with accompanying sclerosis, as indicated by imaging or biopsy results. If fibrosis is present without sclerosis, K74.0 should be selected instead.
Documentation should include liver function tests, imaging studies, and a definitive liver biopsy report indicating the presence of fibrosis and sclerosis. Clinical notes should detail the patient's history of liver disease and any relevant symptoms.
